{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:30:37Z","timestamp":1792290637806,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.molimm.2014.08.003","type":"journal-article","created":{"date-parts":[[2014,9,2]],"date-time":"2014-09-02T09:19:40Z","timestamp":1409649580000},"page":"320-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["In vitro stimulation with HBV therapeutic vaccine candidate Nasvac activates B and T cells from chronic hepatitis B patients and healthy donors"],"prefix":"10.1016","volume":"63","author":[{"given":"Yadira","family":"Lobaina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Hardtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio Cesar","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Schlaphoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2014.08.003_bib0005","series-title":"Cellular and Molecular Immunology","author":"Abbas","year":"2012"},{"key":"10.1016\/j.molimm.2014.08.003_bib0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.0818-9641.2004.01278.x","article-title":"Development of a nasal vaccine for chronic hepatitis infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen","volume":"82","author":"Aguilar","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.molimm.2014.08.003_bib0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijid.2006.09.010","article-title":"Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens","volume":"11","author":"Aguilar-Betancourt","year":"2007","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.molimm.2014.08.003_bib0020","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3851\/IMP1637","article-title":"Immune modulator and antiviral potential of dendritic cells pulsed with both hepatitis B surface antigen and core antigen for treating chronic HBV infection","volume":"15","author":"Akbar","year":"2010","journal-title":"Antiviral Ther."},{"issue":"S1","key":"10.1016\/j.molimm.2014.08.003_bib0025","first-page":"647A","article-title":"A phase III clinical trial with a therapeutic vaccine containing both HBsAg and HBcAg administered via both mucosal and parenteral routes in patients with chronic hepatitis B","volume":"58","author":"Akbar","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.molimm.2014.08.003_bib0030","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s12072-013-9486-4","article-title":"Therapeutic potential of a combined hepatitis B virus surface and core antigen vaccine in patients with chronic hepatitis B","volume":"7","author":"Al-Mahtab","year":"2013","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.molimm.2014.08.003_bib0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2014.08.003_bib0040","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.4049\/jimmunol.176.6.3498","article-title":"Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells","volume":"176","author":"Crawford","year":"2006","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2014.08.003_bib0045","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood.V84.5.1402.1402","article-title":"The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen","volume":"84","author":"Engel","year":"1994","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.molimm.2014.08.003_bib0050","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molimm.2014.08.003_bib0055","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2014.08.003_bib0060","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1084\/jem.20061800","article-title":"Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade","volume":"203","author":"Freeman","year":"2006","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.molimm.2014.08.003_bib0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2893.2007.00922.x","article-title":"Vaccines and immunotherapies against hepatitis B and hepatitis C viruses","volume":"14","author":"Inchauspe","year":"2007","journal-title":"J. Viral Hepat."},{"issue":"14","key":"10.1016\/j.molimm.2014.08.003_bib0070","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1128\/JVI.75.14.6367-6374.2001","article-title":"Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells","volume":"75","author":"Lazdina","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2014.08.003_bib0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1099\/vir.0.18678-0","article-title":"Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent","volume":"84","author":"Lazdina","year":"2003","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.molimm.2014.08.003_bib0080","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/vim.2010.0024","article-title":"The effect of the parenteral route of administration on the immune response to simultaneous nasal\u2013parenteral immunizations using a new HBV therapeutic vaccine candidate","volume":"23","author":"Lobaina","year":"2010","journal-title":"Viral Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2014.08.003_bib0085","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/S1386-6532(05)80019-8","article-title":"Therapeutic vaccination against chronic hepatitis B virus infection","volume":"34","author":"Michel","year":"2005","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.molimm.2014.08.003_bib0090","doi-asserted-by":"crossref","first-page":"14648","DOI":"10.1073\/pnas.94.26.14648","article-title":"Role of B cells in antigen presentation of the hepatitis B core","volume":"94","author":"Milich","year":"1997","journal-title":"Procedia Natl. Acad. Sci."},{"key":"10.1016\/j.molimm.2014.08.003_bib0095","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nri956","article-title":"Natural killer cells and dendritic cells: rendezvous in abused tissues","volume":"2","author":"Moretta","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2014.08.003_bib0100","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1128\/IAI.01559-08","article-title":"Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytes","volume":"77","author":"Negri","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2014.08.003_bib0105","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1053\/j.gastro.2009.05.047","article-title":"Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections","volume":"137","author":"Oliviero","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molimm.2014.08.003_bib0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2010.10.016","article-title":"Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections","volume":"55","author":"Oliviero","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molimm.2014.08.003_bib0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2567.2008.02896.x","article-title":"Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus","volume":"126","author":"Op den Brouw","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2014.08.003_bib0120","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.4049\/jimmunol.168.10.4951","article-title":"Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain","volume":"168","author":"Riedl","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2014.08.003_bib0125","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/eji.200425732","article-title":"B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner","volume":"35","author":"Rodriguez-Pinto","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2014.08.003_bib0130","first-page":"88","article-title":"Differential presentation of hepatitis B S-preS(2) particles and peptides by macrophages and B-cell like antigen-presenting cells","volume":"73","author":"Scheerlinck","year":"1991","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.molimm.2014.08.003_bib0135","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1371\/journal.pone.0008761","article-title":"Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination","volume":"5","author":"Scott-Algara","year":"2010","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.molimm.2014.08.003_bib0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.18553\/jmcp.2008.14.1.61","article-title":"The search for cost-effective treatment of chronic hepatitis B","volume":"14","author":"Smith","year":"2008","journal-title":"JMCP"},{"key":"10.1016\/j.molimm.2014.08.003_bib0145","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1099\/0022-1317-83-9-2279","article-title":"LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles","volume":"83","author":"Vanlandschoot","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.molimm.2014.08.003_bib0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.antiviral.2003.08.011","article-title":"The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure","volume":"60","author":"Vanlandschoot","year":"2003","journal-title":"Antiviral Res."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589014001977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589014001977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:28:19Z","timestamp":1758979699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589014001977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0161589014001977"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2014.08.003","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro stimulation with HBV therapeutic vaccine candidate Nasvac activates B and T cells from chronic hepatitis B patients and healthy donors","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2014.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}